IDXG
INTERPACE BIOSCIENCES, INC.
Key Financials
Net Income
$24.6M
↑ 266.7%
Gross Profit
$24.1M
↓ 19.4%
Revenue
$38.7M
↓ 17.5%
Operating Income
$4.1M
↓ 49.6%
EPS (Diluted)
$0.89
↑ 122.5%
Total Assets
$33.8M
↑ 128.8%
Cash & Equivalents
$2.5M
↑ 71.5%
Shareholders' Equity
$22.4M
↑ 1108.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-1/A | 10/1/2026 | View on SEC |
| S-1 | 9/25/2026 | View on SEC |
| S-8 | 9/17/2026 | View on SEC |
| 8-K | 8/27/2026 | View on SEC |
| 8-K/A | 8/26/2026 | View on SEC |
| 8-K | 8/21/2026 | View on SEC |
| 4 | 8/20/2026 | View on SEC |
| 4 | 8/20/2026 | View on SEC |
| 4 | 8/20/2026 | View on SEC |
| 4 | 8/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IDXG |
| Company Name | INTERPACE BIOSCIENCES, INC. |
| CIK | 1054102 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 412-224-6100 |